Lebwohl M - Search Results

1

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.

Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K; UNCOVER-2 and UNCOVER-3 investigators. Griffiths CE, et al. Among authors: lebwohl m. Lancet. 2015 Aug 8;386(9993):541-51. doi: 10.1016/S0140-6736(15)60125-8. Epub 2015 Jun 10. Lancet. 2015. PMID: 26072109 Clinical Trial.

2

New treatments for alopecia areata.

Lebwohl M. Lebwohl M. Lancet. 1997 Jan 25;349(9047):222-3. doi: 10.1016/S0140-6736(05)64857-X. Lancet. 1997. PMID: 9014905 No abstract available.

3

Psoriasis and stress.

Lebwohl M, Tan MH. Lebwohl M, et al. Lancet. 1998 Jan 10;351(9096):82. doi: 10.1016/S0140-6736(05)78153-8. Lancet. 1998. PMID: 9439490 No abstract available.

4

Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis: effects on the duration of improvement.

Lebwohl M, Yoles A, Lombardi K, Lou W. Lebwohl M, et al. J Am Acad Dermatol. 1998 Sep;39(3):447-50. doi: 10.1016/s0190-9622(98)70323-8. J Am Acad Dermatol. 1998. PMID: 9738781 Clinical Trial.

5

Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?

Krueger GG, Feldman SR, Camisa C, Duvic M, Elder JT, Gottlieb AB, Koo J, Krueger JG, Lebwohl M, Lowe N, Menter A, Morison WL, Prystowsky JH, Shupack JL, Taylor JR, Weinstein GD, Barton TL, Rolstad T, Day RM. Krueger GG, et al. Among authors: lebwohl m. J Am Acad Dermatol. 2000 Aug;43(2 Pt 1):281-5. doi: 10.1067/mjd.2000.106374. J Am Acad Dermatol. 2000. PMID: 10906652

6

Consensus conference: acitretin in combination with UVB or PUVA in the treatment of psoriasis.

Lebwohl M, Drake L, Menter A, Koo J, Gottlieb AB, Zanolli M, Young M, McClelland P. Lebwohl M, et al. J Am Acad Dermatol. 2001 Oct;45(4):544-53. doi: 10.1067/mjd.2001.116347. J Am Acad Dermatol. 2001. PMID: 11568745 Review.

7

A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis.

Lebwohl M, Sherer D, Washenik K, Krueger GG, Menter A, Koo J, Feldman SR. Lebwohl M, et al. Int J Dermatol. 2002 May;41(5):269-74. doi: 10.1046/j.1365-4362.2002.01431.x. Int J Dermatol. 2002. PMID: 12100701 Clinical Trial.

8

Newly available treatments for psoriatic arthritis and their impact on skin psoriasis.

Galadari H, Fuchs B, Lebwohl M. Galadari H, et al. Among authors: lebwohl m. Int J Dermatol. 2003 Mar;42(3):231-7. doi: 10.1046/j.1365-4362.2003.01449.x. Int J Dermatol. 2003. PMID: 12653923 Review.

9

Psoriasis.

Lebwohl M. Lebwohl M. Lancet. 2003 Apr 5;361(9364):1197-204. doi: 10.1016/S0140-6736(03)12954-6. Lancet. 2003. PMID: 12686053 Review.

10

An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis.

Lebwohl M, Christophers E, Langley R, Ortonne JP, Roberts J, Griffiths CE; Alefacept Clinical Study Group. Lebwohl M, et al. Arch Dermatol. 2003 Jun;139(6):719-27. doi: 10.1001/archderm.139.6.719. Arch Dermatol. 2003. PMID: 12810502 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

716 results

Search Page